LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.58 | 84.90 | 15 | 663 | 0.0226 | -0.4426 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.58 | 84.90 | 1220 | 663 | 1.8390 | 1.4560 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.29 | 84.90 | 24 | 766 | 0.0313 | -0.3283 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.29 | 84.90 | 1278 | 766 | 1.6665 | 1.3490 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.29 | 84.90 | 23 | 766 | 0.0300 | -0.3372 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.29 | 84.90 | 1293 | 766 | 1.6861 | 1.3577 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 17.99 | 84.90 | 29 | 898 | 0.0323 | -0.2706 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 17.99 | 84.90 | 1389 | 898 | 1.5451 | 1.2726 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 17.99 | 84.90 | 55 | 898 | 0.0612 | -0.1197 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 17.99 | 84.90 | 1408 | 898 | 1.5662 | 1.2817 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 19.69 | 84.90 | 44 | 1239 | 0.0355 | -0.1563 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 19.69 | 84.90 | 1522 | 1239 | 1.2280 | 1.1091 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 19.69 | 84.90 | 74 | 1239 | 0.0597 | -0.0349 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 19.69 | 84.90 | 1557 | 1239 | 1.2562 | 1.1215 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 21.40 | 84.90 | 75 | 1454 | 0.0516 | -0.0298 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 21.40 | 84.90 | 1646 | 1454 | 1.1315 | 1.0612 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 21.40 | 84.90 | 78 | 1454 | 0.0536 | -0.0205 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 21.40 | 84.90 | 1692 | 1454 | 1.1632 | 1.0751 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 23.10 | 84.90 | 71 | 1616 | 0.0439 | -0.0412 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 23.10 | 84.90 | 1791 | 1616 | 1.1081 | 1.0489 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 23.10 | 84.90 | 106 | 1616 | 0.0656 | 0.0536 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 23.10 | 84.90 | 1836 | 1616 | 1.1360 | 1.0609 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.81 | 84.90 | 111 | 1769 | 0.0627 | 0.0631 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.81 | 84.90 | 1888 | 1769 | 1.0670 | 1.0298 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.81 | 84.90 | 129 | 1769 | 0.0729 | 0.1002 | MN20160318_Q02 | N15 |